Skip to content

Clinical trials

Completed Muscular Dystrophy, Duchenne trials in Belgium

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Muscular Dystrophy, Duchenne Status: Completed Country / region: Belgium Clear all

18 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20061
20082
20092
20102
20121
20131
20161
20173
20182
20211
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed18

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
PTC Therapeutics3
Santhera Pharmaceuticals3
Sarepta Therapeutics, Inc.3
GlaxoSmithKline2
BioMarin Pharmaceutical1
Edgewise Therapeutics, Inc.1
Hoffmann-La Roche1
Italfarmaco1
ReveraGen BioPharma, Inc.1
Universitaire Ziekenhuizen KU Leuven1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Muscular Dystrophy, Duchenne18
Muscular Dystrophies5
Neuromuscular Diseases2
Genetic Diseases, Inborn1
Genetic Diseases, X-Linked1
Insulin Resistance1
Muscular Diseases1
Muscular Disorders, Atrophic1
Musculoskeletal Diseases1
Nervous System Diseases1

Trials

Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.